Magnetic resonance imaging (MRI) could become a valuable tool for predicting the risk of muscle injury during and following radiation therapy, according to investigators at St. Jude Children’s Research Hospital.
Biologists have invented a chemical-free, hairdryer-like device — the LouseBuster — and conducted a study showing it eradicates head lice infestations on children by exterminating the eggs, or “nits,” and killing enough lice to prevent them from reproducing.
Some patients who experience recurrent depression may benefit from long-term maintenance treatment with anti-depressant medication, according to a new study led by a Virginia Commonwealth University researcher.
A postmenopausal hormone therapy trial conducted in Estonia indicates that hormone therapy does not improve women’s quality of life. The group receiving hormones and the comparison group showed no differences in general quality of life. Only those women that experienced hot flashes and night-time sweating reported beneficial effects.
The eye can provide a very reliable way of diagnosing cerebral malaria, researchers in Malawi have shown. By looking at the changes to the retina, doctors are able to determine whether an unconscious child is suffering from this severe form of malaria or another, unrelated illness, leading to the most appropriate treatment.
Doctors have created a first-ever computer tool to predict the risk of breast cancer returning in the same breast over a 10-year period in women who have had breast conserving surgery to remove only the cancer (lumpectomy), according to a study presented November 6, 2006, at the American Society for Therapeutic Radiology and Oncology’s 48th Annual Meeting in Philadelphia.
The Centre for Health Protection has cautioned the public to be vigilant against methicillin-resistant Staphylococcus aureus, as many places, including Hong Kong, have seen its occurrence in the community.
The worrying state of infection control practices in the NHS has been revealed in a damning new report.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Syrup, 5 mg/5 mL. Total annual market sales for Cetirizine Hydrochloride Syrup were $146.3 million (IMS ? MAT: June 2006).
Each year in the United States, 23.5 million children travel 4.3 billion miles on 450,000 school buses — and a new study shows that kids may not be as safe as previously thought. Researchers at the Columbus Children’s Research Institute in Columbus, Ohio, found that an estimated 17,000 injuries occur annually — three times more than previously reported.